Olaf Prien is the EVP and Head of Preclinical Compound Profiling at Nuvisan Pharma Services Group since July 2020. Prior to that, Olaf held various key roles at Bayer Pharmaceuticals, including Head Preclinical Compound Profiling at Innovation Campus Berlin, Head Drug Metabolism Berlin, and Labhead Drug Metabolism from May 2007 to June 2020.
Sign up to view 7 direct reports
Get started